| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/17/2005 | US20050037024 Matrix metalloprotease inhibitor |
| 02/17/2005 | US20050037009 Methods and reagents for protease inhibition |
| 02/17/2005 | US20050037005 5c8 Antigen |
| 02/17/2005 | US20050037004 An aglycosylated antibody having a binding affinity for the CD3 antigen complex; antiinflammatory, antiarthritic agents |
| 02/17/2005 | US20050036985 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/17/2005 | CA2535125A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2535066A1 Macrophage activation inhibitor |
| 02/17/2005 | CA2534905A1 Pyridyl piperazinyl ureas |
| 02/17/2005 | CA2534496A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2534471A1 Method and apparatus for producing ultrafine drug particles |
| 02/17/2005 | CA2533464A1 Thiazole derivatives as npy antagonists |
| 02/17/2005 | CA2533124A1 Use of cxcl6 chemokine in the prevention or repair of cartilage defects |
| 02/17/2005 | CA2532948A1 Combinations of a cathepsin k inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss |
| 02/17/2005 | CA2529623A1 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 02/16/2005 | EP1506967A1 Dipeptidyl peptidase inhibitors |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506951A1 Preparation and application of transhintotalphenolic acid |
| 02/16/2005 | EP1506785A1 Composition for treating or preventing hyperuricemia |
| 02/16/2005 | EP1506285A2 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 02/16/2005 | EP1506228A2 Role of p62 in aging-related disease |
| 02/16/2005 | EP1506204A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 02/16/2005 | EP1506202A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof |
| 02/16/2005 | EP1506193A1 Carbamate-substituted pyrazolopyridines |
| 02/16/2005 | EP1506192A1 Substituted pyrroline kinase inhibitors |
| 02/16/2005 | EP1506191A1 Benzoxazine and benzoxazinone substituted triazoles |
| 02/16/2005 | EP1506187A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 02/16/2005 | EP1506186A1 Substituted heterocyclic compounds and methods of use |
| 02/16/2005 | EP1506178A2 Bicyclic modulators of androgen receptor function |
| 02/16/2005 | EP1506041A1 Bisphosphonic acids for the treatment and prevention of osteoporosis |
| 02/16/2005 | EP1506014A1 Process for the preparation and activation of substances and a means of producing same |
| 02/16/2005 | EP1506002A2 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
| 02/16/2005 | EP1505984A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 02/16/2005 | EP1505982A1 Trimegestone and estrogens for treating post menopausal disorders |
| 02/16/2005 | EP1505979A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles |
| 02/16/2005 | EP1505973A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1425258A4 Hydroxyeicosenoic acid analogs |
| 02/16/2005 | EP1296698A4 Therapeutic agents - ii |
| 02/16/2005 | EP1296697A4 Therapeutic agents - i |
| 02/16/2005 | EP1246814B1 Compounds and methods for modulation of estrogen receptors |
| 02/16/2005 | EP1240166B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl carboxamide inhibitors of cyclin dependent kinases |
| 02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 02/16/2005 | EP1037906B1 Cyclopeptide derivatives with integrin inhibitor properties |
| 02/16/2005 | EP0833643B1 Anhydrous alendronate monosodium salt formulations and their use for the treatment of bone diseases |
| 02/16/2005 | CN1582522A Intelligent serial cell charger and charging circuit block |
| 02/16/2005 | CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/16/2005 | CN1582287A Thiophenylthiopyrane dioxides as MMP or TNF-alpha inhibitors |
| 02/16/2005 | CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
| 02/16/2005 | CN1582276A Phenylalanine enamide derivatives |
| 02/16/2005 | CN1582275A Calcium antagonistic compound |
| 02/16/2005 | CN1582271A Inhibitors of integrin alpha v beta 6 |
| 02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
| 02/16/2005 | CN1582164A Antigen arrays for treatment of bone disease |
| 02/16/2005 | CN1582161A Pharmatceutical Formualtion comprising cyclosporin and use thereof |
| 02/16/2005 | CN1582158A Novel therapeutic indication of azithromycin for treatment of non-infective inflammatory diseases |
| 02/16/2005 | CN1582152A composition of estrogen and other hormons with ascorbate, lysine, proline and other substances |
| 02/16/2005 | CN1582150A Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 02/16/2005 | CN1579542A Lugua polypeptides for injection and its preparing process |
| 02/16/2005 | CN1579541A Compound bone peptide for injection and its preparation process |
| 02/16/2005 | CN1579540A Gugua polypeptides for injection and its preparing method |
| 02/16/2005 | CN1579529A Donky-hide bone-strengthening composition and its production method |
| 02/16/2005 | CN1579517A Quick-acting medicated liquor for treating traumatic injury |
| 02/16/2005 | CN1579509A Method for making traditional Chinese medicine for treating hyperosteogeny |
| 02/16/2005 | CN1579505A Gucining preparation for treating spur and preparation method thereof |
| 02/16/2005 | CN1579492A Resina draconis and its total flavone solution preparation and its preparation method |
| 02/16/2005 | CN1579478A Capsule for treating osteonecrosis and bone fracture |
| 02/16/2005 | CN1579464A Medicine for treating traumatic injury and its preparation method |
| 02/16/2005 | CN1579463A Compound cape-jasmine salted-fermented beans total extract and its preparation and use |
| 02/16/2005 | CN1579453A Anti-rheumatism medicated spirit for treating rheumatic arthritis and rheumatoid arthritis |
| 02/16/2005 | CN1579450A She medicinal composition for treating bone fracture and relieving pain, and its cataplasm and preparation process thereof |
| 02/16/2005 | CN1579444A Medicine for treating spur and protrusion of intervertebral disc and rheumatism, its preparation and using method |
| 02/16/2005 | CN1579442A Medicine for treating osteoporosis and its production method |
| 02/16/2005 | CN1579440A Medicinal plaster for treating cervical vertebra disease |
| 02/16/2005 | CN1579385A New Preparation of Gantaile |
| 02/16/2005 | CN1579369A Cuyantong slow-releasing round-particle composition and preparation method |
| 02/16/2005 | CN1189482C Novel angiogenesis inhibitor |
| 02/16/2005 | CN1189479C Use of leptin in inhibition of endothelial cell proliferation |
| 02/16/2005 | CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/16/2005 | CN1189465C Vitamin D3 analogs with bis C-20 side chains |
| 02/16/2005 | CN1189201C Externally applied Chinese medicine for treating osteoarthropathy and its prepn process |
| 02/16/2005 | CN1189194C Medicine for curing cervucal spondylopathy and verebrae lumbales diseases |
| 02/16/2005 | CN1189192C Chiense medicine for treating bone fracture |
| 02/16/2005 | CN1189168C Use of (-)-(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2-diabetes, hyperlipidemia and hyperuricemia |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/15/2005 | US6855808 Prevent cell differentiation; culture product; genetic engineered protein |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855719 Nitrogen compounds such as 2-(3-Chloroanilino)-4-(2-methyl-imidazo(1,2a)pyrid-3-yl)pyrimidine, used as cyclin dependent kinase inhibitors or as anticarcinogenic agents |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/15/2005 | US6855703 Triene steroids administered to mammals for prophylaxis of diseases and disorders such as cancer, menopause or osteoporosis |
| 02/15/2005 | US6855689 Anticancer agents |
| 02/15/2005 | US6855687 Administering to the site in need of cartilage repair a polypeptide having the sequence Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Cys-Glu-Gl y-Asp-Ser-Pro-Phe-Val |
| 02/15/2005 | US6855532 Gene therapy; drug screening |
| 02/15/2005 | US6855528 Administering a covalently reactive antigen analog (CRAA) having an an epitope recognized irreversibly bound by catalytic antibody; autoimmune disease; a lymphoproliferative disorder; anticarcinogenic, -tumor, -inflammatory agents |
| 02/15/2005 | US6854468 Treatment of subnormal bone mineral density |
| 02/15/2005 | CA2303764C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 02/14/2005 | CA2477359A1 Pyruvate enriched onion extract |
| 02/10/2005 | WO2005012272A1 Benzoxazepine compound |